Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of CCX 354 in volunteers

Trial Profile

Phase I trial of CCX 354 in volunteers

Phase of Trial: Phase I

Latest Information Update: 09 Nov 2010

At a glance

  • Drugs CCX 354 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors ChemoCentryx
  • Most Recent Events

    • 09 Nov 2010 Results were reported at the Annual American College of Rheumatology Meeting (ACR), according to a ChemoCentryx media release.
    • 17 Jun 2010 Pooled analysis presented at the 11th Annual Congress of the European League Against Rheumatism.
    • 17 Jun 2010 Results of this trial have been presented at the 2010 Annual European Congress of Rheumatology (EULAR), according to a ChemoCentryx media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top